We report here that JNK/SAPKs are activated by TRAIL in parallel to inducti
on of apoptosis in human T and B cell lines. Death signaling as well as JNK
/SAPK activation by TRAIL in these cells is FADD- and caspase-dependent sin
ce dominant-negative FADD or the caspase inhibitor zVAD prevented both, apo
ptosis and JNK/SAPK activity. JNK/SAPK activity in response to triggering o
f CD95 by an agonistic antibody (alpha APO-1) was also diminished by domina
nt-negative FADD or zVAD. Correspondingly, a cell line resistant to alpha A
PO-1-induced death exhibited crossresistance to TRAIL-induced apoptosis and
did not upregulate JNK/SAPK activity in response to TRAIL or alpha APO-1.
Inhibition of JNK/SAPK activity, by stably transfecting cells with a domina
nt-negative JNKK-MKK4 construct, reduced apoptosis in response to TRAIL or
alpha APO-1. Therefore, activation of JNK/SAPKs by TRAIL or alpha APO-1 occ
urs downstream of FADD and caspases and contributes to apoptosis in human l
ymphoid cell lines.